ALPN Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (17 mai 2024 @ 22:00):
Our systems believe the stock currently is undervalued by 0.11% compare to its pairs and should correct upwards.

Stats
Dagens volum	4.29M
Gjennomsnittsvolum	2.37M
Markedsverdi	4.46B
EPS	$-0.280 ( Q1 \| 2024-05-09 )
Neste inntjeningsdato	( $-0.420 ) 2024-08-12
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-101.52 (Sector) 42.63 (Industry) 24.32
ATR14	$0.00600 (0.01%)

AADI -6.18%

ABCL 0.92%

ABCM 0.04%

ABEO -2.89%

ABIO -0.30%

ABOS 5.14%

ABSI 2.89%

ABUS -0.98%

ABVX -3.00%

ACAD -0.42%

ACER -17.95%

ACET -8.87%

ACGN 1.29%

ACHL -1.70%

ACHV 2.26%

ACIU -0.25%

ACLX -0.58%

ACRV -4.63%

ACST -3.58%

ACXP 3.69%

ADAG 7.14%

ADAP -3.65%

ADGI 0.87%

ADIL -3.68%

ADMA -1.23%

ADPT 0.44%

ADTX -3.47%

ADVM 1.16%

ADXN -1.60%

AEON -4.67%

AEZS -2.49%

AFMD -2.97%

AGEN -3.93%

AGIO -2.63%

AGLE 6.66%

AGTC 0.00%

AIKI 0.85%

AIMDW -13.88%

AKBA 8.24%

AKRO -2.68%

AKTX -5.23%

AKUS 0.00%

ALBO 0.00%

ALDX -2.40%

ALEC -0.69%

ALGS -3.03%

ALKS 1.80%

ALLK -11.06%

ALLO -3.96%

ALLR -1.63%

ALNA 3.16%

ALNY 2.41%

ALPN 0.02%

ALPX 0.00%

ALRN -1.67%

ALT -15.67%

ALVR -1.00%

ALXN 0.00%

ALXO -10.79%

ALZN 5.10%

AMRN -3.06%

AMTI -3.13%

ANAB 1.53%

ANEB 7.95%

ANGN 0.00%

ANIX -3.64%

ANL -0.14%

ANNX 3.93%

ANPC -3.15%

APGE 1.40%

APGN 8.48%

APGNW 30.65%

APLM -5.86%

APLS 0.15%

APLT 0.90%

APM 1.47%

APOP 0.38%

APRE -3.13%

APTO 0.62%

APTX 3.17%

APVO 0.38%

ARAV -13.39%

ARCT -6.43%

ARDS -12.13%

ARDX 2.08%

ARGX -0.68%

ARNA 0.00%

ARPO -0.90%

ARQT -2.71%

ARTL -2.50%

ARTLW 0.00%

ARVN 7.07%

ARWR -2.53%

ASLN -4.68%

ASMB -5.55%

ASND -2.08%

ATAI -3.70%

ATHA 7.27%

ATHE 0.08%

ATHX -33.50%

ATNF 2.18%

ATOS 4.85%

ATRA -5.91%

ATXI 2.68%

ATXS -0.55%

AUPH -0.99%

AURA 4.55%

AUTL -3.59%

AVBP -0.80%

AVEO 0.00%

AVIR -1.60%

AVRO -1.41%

AVTE -1.03%

AVTX -4.23%

AVXL -5.56%

AXLA 0.00%

AXSM -1.29%

AYLA 0.00%

AZRX 2.07%

BBI 2.17%

BBIO 1.07%

BCAB -7.17%

BCDA -0.85%

BCDAW -46.41%

BCEL 0.00%

BCLI 3.09%

BCRX 1.89%

BCTX 13.26%

BCTXW 13.02%

BCYC 1.15%

BDRX -5.56%

BDTX 0.00%

BEAM 2.60%

BFRA -2.91%

BGNE -3.20%

BIOR -3.94%

BIVI 2.12%

BLCM -6.68%

BLI -5.88%

BLPH 0.00%

BLRX -2.60%

BLTE -1.44%

BLU 0.03%

BLUE -5.14%

BMEA -15.16%

BMRN 0.18%

BNOX 4.46%

BNTC -3.06%

BNTX -2.09%

BOLD -11.71%

BOLT -0.19%

BPMC -2.24%

BPTH -4.05%

BPTS -13.47%

BRNS -0.37%

BRTX -5.24%

BTAI 14.79%

BTTX 20.00%

BTX 0.05%

BVXV 0.74%

BXRX 7.39%

BYSI 1.70%

CABA 0.55%

CADL 0.89%

CALA 0.00%

CALC -8.48%

CALT -1.59%

CAPR -0.22%

CARA -11.93%

CARM 6.52%

CASI -1.18%

CATB -6.97%

CBAY 0.03%

CBIO -2.65%

CBLI -7.31%

CBUS 0.22%

CCCC -2.23%

CCXI 0.00%

CDAK 0.00%

CDIO -4.88%

CDIOW 24.00%

CDMO -1.34%

CDMOP 0.04%

CDT -4.88%

CDTTW -39.60%

CDTX -6.28%

CDXC 9.63%

CDXS 9.12%

CELC -3.61%

CELU 0.74%

CELUW 11.80%

CERC -1.68%

CERE -1.42%

CERO -5.03%

CEROW -10.18%

CFRX -27.95%

CGEM -0.40%

CGEN -3.33%

CGON -2.42%

CGTX -3.43%

CHMA -6.00%

CHRS 5.06%

CINC 0.00%

CING 0.34%

CINGW 34.95%

CKPT -0.48%

CLBS -16.75%

CLDX -0.58%

CLGN -0.40%

CLLS -3.11%

CLNN -1.39%

CLNNW 0.00%

CLRB 5.93%

CLSD -3.34%

CLSN -0.68%

CLVS 0.00%

CMMB -2.94%

CMND 3.23%

CMPI 0.00%

CMPX 1.89%

CMRA 0.00%

CMRAW 33.33%

CMRX -4.55%

CNCE 0.00%

CNSP -33.34%

CNST 0.00%

CNTA 0.31%

CNTB -1.50%

CNTX -5.25%

COCP -1.83%

COEPW 32.45%

COGT -2.58%

CORT 3.36%

COYA -0.65%

CPRX -1.62%

CRBP -1.89%

CRBU -7.95%

CRDF 1.77%

CRGX -1.28%

CRIS -2.64%

CRNX -6.15%

CRSP 1.04%

CRTX 2.63%

CRVO -3.58%

CRVS 0.28%

CSBR -0.19%

CTCX 1.20%

CTIC 0.06%

CTMX -3.72%

CTNM 3.71%

CTXR -4.48%

CUE -2.77%

CVAC -5.08%

CVKD -2.34%

CWBR 2.80%

CYAD -12.96%

CYCC 23.15%

CYCCP 5.28%

CYCN 7.81%

CYT -2.27%

CYTK -2.56%

CYTO 0.86%

DARE 0.86%

DAWN -0.34%

DBTX -0.81%

DBVT 4.17%

DFFN 10.28%

DICE 0.06%

DMAC 30.36%

DNLI -2.14%

DNTH -2.52%

DOMH 1.06%

DRMA -2.57%

DRMAW -1.25%

DRNA 0.00%

DRTS 0.46%

DRTSW 0.00%

DRUG -0.10%

DSGN -2.72%

DTIL -0.21%

DYAI 9.68%

EARS -1.77%

EDIT -3.22%

EDSA 4.14%

EFTR 1.49%

EFTRW -51.85%

EIGR -9.21%

ELAB -3.01%

ELDN 7.56%

ELEV -2.08%

ELOX 10.77%

ELTX -3.38%

ELVN -0.70%

ELYM 4.67%

ENGN 0.49%

ENGNW -21.67%

ENLV -1.45%

ENOB 1.79%

ENSC 6.55%

ENTA -1.06%

ENTO -4.97%

ENTX 0.53%

ENVB -0.02%

EPIX -2.68%

EPRX -2.89%

EPZM 0.00%

EQ -1.24%

EQRX -2.09%

EQRXW 0.00%

ERAS 6.00%

ERNA -2.78%

ERYP 1.30%

ESLA 4.30%

ESLAW 16.64%

ETNB -5.92%

ETON 2.59%

ETTX 0.00%

EVAX 0.00%

EVGN 2.78%

EVLO 0.00%

EWTX 0.20%

EXAI -0.57%

EXEL 0.67%

EYEG -0.69%

EYEN 0.00%

EYPT 0.18%

FATE -12.23%

FBIO 0.59%

FBIOP 0.87%

FBLG -10.70%

FBRX -0.04%

FDMT -4.95%

FENC -2.74%

FGEN -9.83%

FHTX 7.82%

FIXX 0.77%

FMTX 0.00%

FNCH 0.00%

FOLD -1.87%

FREQ 4.76%

FRLN 0.15%

FRTX 0.00%

FSTX 0.00%

FTRE 0.89%

FULC 2.51%

FUSN 0.00%

FWBI 4.59%

FWP 0.00%

GALT -1.35%

GANX -1.54%

GBIO -0.71%

GBT 0.01%

GDTC 0.50%

GERN -1.66%

GHRS -4.26%

GLMD -3.02%

GLPG -1.87%

GLSI 9.23%

GLTO -3.86%

GLUE -2.51%

GLYC -15.03%

GMAB -0.38%

GMDA -18.25%

GMTX 0.00%

GNCA -85.71%

GNFT -2.34%

GNLX -5.31%

GNPX -4.41%

GNTA 3.94%

GOSS -8.23%

GOVX -5.00%

GOVXW 10.89%

GPCR -6.83%

GRAY -10.80%

GRCL 0.05%

GRNA -0.03%

GRNAW 8.91%

GRPH -2.75%

GRTS -2.14%

GRTX -1.66%

GTHX 3.18%

GUTS -0.23%

GXGXW 41.67%

GYRE -6.30%

HALO -1.11%

HARP 0.09%

HCWB -10.05%

HEPA -3.50%

HGEN -84.62%

HILS 5.66%

HLVX -1.38%

HOOK 2.03%

HOTH -0.82%

HOWL 0.21%

HRMY 2.23%

HRTX 8.36%

HSTO 0.00%

HUMA 1.32%

HUMAW -6.25%

IBRX -6.88%

ICCC -2.10%

ICPT 0.21%

ICU 18.71%

ICUCW 4.86%

ICVX -0.91%

IDRA -23.04%

IDYA -3.35%

IFRX -3.12%

IGMS -2.05%

IKNA -0.89%

IKT 0.00%

IMAB -0.58%

IMCR -3.55%

IMGN 0.02%

IMGO 0.00%

IMMP 5.51%

IMMX -6.01%

IMNM 3.64%

IMNN 1.77%

IMPL -27.27%

IMRA 15.96%

IMRN -0.40%

IMRX -3.52%

IMTX -1.42%

IMTXW 6.00%

IMUX -2.78%

IMV 0.00%

IMVT -3.79%

INAB -1.68%

INBX -3.08%

INCY -1.95%

INDP 6.88%

INFI -52.38%

INKT -0.46%

INM 3.06%

INMB 3.50%

INO 2.15%

INSM -0.76%

INTS -3.73%

INVA 0.77%

INZY 1.60%

IOBT -7.11%

IONS 1.44%

IOVA -4.02%

IPA 0.03%

IPHA 2.54%

IPSC -2.35%

IRON -2.09%

ISEE 0.38%

ITOS 2.70%

ITRM 1.51%

IVA 6.96%

IVVD 0.00%

JAGX 0.52%

JANX -5.18%

JAZZ -0.93%

JNCE 0.00%

JSPR -2.11%

JSPRW 20.88%

JUNS 0.00%

JUNSW 0.00%

KA -2.47%

KALV -2.60%

KDNY 0.22%

KMPH -0.34%

KNSA -2.42%

KNTE -0.38%

KOD -8.89%

KPRX -5.76%

KPTI -8.85%

KRBP -10.00%

KRON 1.61%

KROS -0.53%

KRRO -1.58%

KRTX 0.03%

KRYS 0.91%

KTRA 10.43%

KTTA -0.65%

KTTAW 0.92%

KURA 0.68%

KYMR -3.53%

KYTX -5.30%

KZIA 7.51%

KZR -1.75%

LABP 0.57%

LBPH 0.02%

LBPS 0.00%

LBPSW 14.81%

LEGN 3.26%

LENZ -2.89%

LEXX 0.58%

LEXXW -14.63%

LGND -0.92%

LGNDV 0.00%

LGVN -9.04%

LIAN -8.28%

LIFE 2.70%

LIPO -5.29%

LIXT -9.76%

LIXTW 46.21%

LJPC -0.32%

LMNL 0.12%

LOGC 0.61%

LPCN -4.36%

LPTX -2.20%

LQDA 0.37%

LRMR -1.21%

LSTA -1.68%

LTRN 5.49%

LUMO 0.67%

LVTX -4.84%

LXEO -12.92%

LXRX -1.47%

LYEL -35.78%

LYRA 4.26%

MACK 0.10%

MBIO -11.14%

MBRX -1.43%

MCRB 2.41%

MDGL -1.90%

MDNA -13.16%

MDWD 3.18%

MDXG -1.77%

MEIP 0.70%

MESO -1.63%

MGNX -5.36%

MGTA -7.74%

MGTX -0.95%

MGX -0.54%

MIRM -0.66%

MIRO 0.59%

MIST 2.62%

MITO 0.00%

MLEC -6.54%

MLECW 2.31%

MLND -5.36%

MLTX 0.84%

MLYS -7.52%

MNKD -0.86%

MNMD 3.04%

MNOV 1.41%

MNPR -8.52%

MOLN 0.76%

MOR 0.62%

MORF -2.91%

MREO 0.00%

MRKR -0.43%

MRNA -10.66%

MRNS -6.03%

MRSN -4.05%

MRTX -0.17%

MRUS 0.39%

MRVI 0.51%

MTCR -1.29%

MTEM 7.43%

MTP -18.50%

MURA -3.87%

MYMD 1.08%

NAMS -0.05%

NAMSW 0.64%

NAUT 0.23%

NBRV 0.71%

NBSE -1.56%

NBTX 8.91%

NCNA -0.18%

NERV -1.58%

NEXI -0.74%

NGM -1.28%

NGNE 4.18%

NKGN 10.92%

NKGNW -20.00%

NKTR 1.87%

NKTX -2.12%

NLSP 2.88%

NLSPW 26.67%

NMRA -1.14%

NMTR -42.97%

NOVN -24.84%

NRBO 12.91%

NRIX -1.54%

NRSN 0.78%

NRSNW 0.00%

NRXP -8.92%

NRXPW 18.33%

NRXS -1.20%

NTBL 2.63%

NTEC -12.45%

NTHI 0.00%

NTLA -4.92%

NTRBW -31.07%

NUVL -1.93%

NVAX -5.71%

NVCT -7.68%

NVIV -34.28%

NXTC -5.88%

NYMX -0.05%

OABI 3.30%

OABIW -10.06%

OBIO 1.17%

OBSV 0.00%

OCEA -4.23%

OCGN 7.63%

OCS -1.00%

OCUL 0.46%

OCUP 0.00%

ODT -4.27%

OKYO 1.72%

OLMA -4.68%

OMER -2.18%

OMGA -2.08%

ONCO 5.46%

ONCR -3.08%

ONCS 31.87%

ONCT -2.04%

ONCY 1.97%

ONTX -0.47%

ONVO 3.72%

OPNT 0.00%

OPT -5.15%

ORGS -0.69%

ORIC -2.52%

ORMP 16.29%

ORPH 0.00%

ORTX 0.30%

OSMT -1.77%

OTIC -92.64%

OTLK -0.56%

OVID 0.01%

OYST 0.00%

PALI -0.48%

PASG 0.00%

PBLA -7.50%

PBM -3.44%

PBYI 4.57%

PCSA 0.00%

PCVX 0.63%

PDSB -5.85%

PEPG 1.49%

PGEN -6.64%

PHAR 1.99%

PHAS 0.00%

PHAT 0.29%

PHIO -3.55%

PHIOW 36.47%

PHVS -6.50%

PHXM -5.20%

PIRS -0.34%

PKBO 0.00%

PKBOW 999 900.00%

PLRX -2.75%

PLUR 10.34%

PMN -5.55%

PMVP -1.19%

PNT 0.16%

PPBT -2.98%

PRAX 5.15%

PRDS 0.93%

PRLD -3.43%

PROG -3.47%

PROK 1.57%

PRQR 1.20%

PRTA -3.42%

PRTC 0.49%

PRTG 1.40%

PRTK 1.83%

PRVB 0.00%

PSTI -2.91%

PSTV -12.20%

PSTX -4.26%

PTCT -0.60%

PTE -0.82%

PTGX 0.44%

PTIXW -48.41%

PULM 1.56%

PXMD 4.76%

PYPD 1.71%

PYXS 4.51%

QLGN -5.56%

QNCX 2.23%

QNRX 0.87%

QSI -29.91%

QSIAW -9.44%

QTTB 2.91%

QURE -1.35%

RAIN -1.63%

RANI 4.28%

RAPT -2.11%

RARE 1.88%

RCKT -10.40%

REGN -0.18%

RENB -3.73%

REPL -2.83%

RETA 0.02%

REUN -0.89%

REVB -1.67%

REVBU 3.46%

REVBW 5.00%

RGLS -5.84%

RGNX -6.66%

RIGL -6.24%

RLAY -5.79%

RLMD 0.94%

RLYB -5.03%

RNA 2.00%

RNAC -1.63%

RNAZ -1.92%

RNXT 2.23%

ROIV -2.26%

ROIVW 4.56%

RPHM -1.87%

RPRX -0.86%

RPTX -1.32%

RUBY 2.70%

RVLP -32.05%

RVMD -0.52%

RVMDW -29.90%

RVNC 0.43%

RVPH -0.40%

RVPHW -5.28%

RXDX 0.09%

RXRX -6.29%

RYTM -5.94%

RYZB 0.02%

RZLT 2.84%

SABS -1.37%

SABSW -5.53%

SAGE -0.60%

SANA -2.40%

SAVA -3.37%

SAVAW 0.00%

SBBP 1.52%

SBTX 1.03%

SCNI 1.28%

SCPH 10.73%

SCPS 0.00%

SEEL -5.01%

SEER 0.30%

SELB -8.00%

SESN 7.29%

SGEN -0.07%

SGMO -4.16%

SGMT -4.83%

SGTX -2.56%

SIOX 22.63%

SLDB -2.41%

SLGL 5.23%

SLN -8.47%

SLNO 0.82%

SLRX 0.40%

SLS -3.85%

SMMT -3.25%

SNDX 1.59%

SNGX 3.40%

SNPX -0.69%

SONN 0.54%

SPPI -0.49%

SPRB -1.68%

SPRC -3.29%

SPRO 0.38%

SRNE 0.00%

SRPT -1.09%

SRRA 0.00%

SRRK -1.55%

SRZN -2.45%

STAB 0.00%

STOK -6.81%

STRO -3.18%

STSA 0.00%

STTK 6.47%

SURF -0.93%

SVRA -3.82%

SWTX -0.38%

SYBX 0.00%

SYRS -1.55%

TALS -0.73%

TARA -9.26%

TARS -2.36%

TBPH 0.18%

TCBP 5.49%

TCDA 0.00%

TCON -0.70%

TCRR 0.00%

TCRT 4.59%

TCRX -2.10%

TECH -1.46%

TENX -0.32%

TERN -7.24%

TFFP -11.28%

TGTX -8.13%

THRX 0.12%

TIL -1.22%

TLC 0.00%

TLSA -4.53%

TNGX -3.14%

TNXP -10.30%

TNYA -5.78%

TPST 5.58%

TRDA -5.08%

TRVI 1.92%

TRVN 3.19%

TSHA -18.70%

TSVT -3.72%

TTNP -6.05%

TVTX 3.89%

TYRA -7.57%

UBX -2.71%

UNCY -4.01%

URGN 3.09%

UTHR -0.24%

VACC 11.36%

VALN -2.96%

VAXX 118.75%

VBIV -0.79%

VBLT -8.77%

VCEL 1.51%

VCNX 9.36%

VCYT -1.01%

VERA -4.40%

VERU 1.31%

VERV -3.82%

VIGL 1.61%

VINC 2.81%

VIR -1.19%

VIRI -5.66%

VIRX 3.85%

VKTX -1.59%

VLON -13.04%

VNDA -3.02%

VOR -5.67%

VRCA 2.13%

VRDN -3.57%

VRNA -2.03%

VRPX 3.58%

VRTX -0.05%

VSTM 4.76%

VTGN -2.11%

VTVT 1.28%

VTYX -1.88%

VXRT -0.91%

VYGR -0.64%

VYNE -5.80%

VYNT 7.78%

WINT -2.72%

WVE -8.70%

XBIO 1.03%

XBIT 5.52%

XCUR 0.23%

XENE -1.00%

XERS 4.99%

XFOR 6.25%

XLO 3.06%

XLRN 0.00%

XNCR -0.05%

XOMA -7.77%

XOMAO -0.45%

XOMAP -0.82%

XRTX -7.96%

YMAB -1.80%

ZGNX 0.00%

ZIOP -0.88%

ZLAB -2.76%

ZNTL -1.31%

ZSAN 0.00%

Insider Trading

Date	Person	Action	Amount	type
2024-05-20	Peetz Christopher	Sell	1 900	Common Stock
2024-05-20	Peetz Christopher	Sell	7 650	Stock Option (Right to buy)
2024-05-20	Peetz Christopher	Sell	7 650	Stock Option (Right to buy)
2024-05-20	Peetz Christopher	Sell	7 650	Stock Option (Right to buy)
2024-05-20	Peetz Christopher	Sell	7 650	Stock Option (Right to buy)

INSIDER POWER
-99.05
Last 100 transactions
Buy: 62 882 \| Sell: 12 958 869

Korrelasjon (AI algo v.1.1b): Undervalued: 0.11% $65.05 paired level. (Algoen sporer endringene til de mest korrelerte aksjene i sanntid og gir umiddelbar oppdatering)

Volum Korrelasjon

Lang: -0.02 (neutral)

Kort: -0.45 (neutral)

Signal:(40.808) Neutral

Alpine Immune Sciences Korrelasjon

10 Mest positive korrelasjoner
NKTR	0.961
BCSA	0.956
IVCB	0.949
NSYS	0.949
BOCN	0.946
GDST	0.941
PRIM	0.939
PAYS	0.938
GALT	0.937
RZLT	0.936

10 Mest negative korrelasjoner
ALLR	-0.966
JACK	-0.959
PERI	-0.958
AKTX	-0.954
WNEB	-0.953
SIRI	-0.952
APVO	-0.95
HAIN	-0.948
XPON	-0.948
OSUR	-0.948

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Alpine Immune Sciences Korrelasjon - Valuta/Råvare

0.43
( neutral )

0.26
( neutral )

0.00
( neutral )

0.08
( neutral )

Alpine Immune Sciences Økonomi

Annual	2023
Omsetning:	$58.88M
Bruttogevinst:	$58.30M (99.02 %)
EPS:	$-0.640

FY	2023
Omsetning:	$58.88M
Bruttogevinst:	$58.30M (99.02 %)
EPS:	$-0.640

FY	2022
Omsetning:	$30.06M
Bruttogevinst:	$29.47M (98.01 %)
EPS:	$-1.730

FY	2021
Omsetning:	$23.44M
Bruttogevinst:	$0.00 (0.00 %)
EPS:	$-1.980

Financial Reports:

No articles found.

Alpine Immune Sciences Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Alpine Immune Sciences

Alpine Immune Sciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of protein-based immunotherapies for the treatment of cancer, autoimmune/inflammatory disorders, and other diseases. Its product pipeline includes ALPN-101, an inducible T cell costimulator (ICOS)/cluster of differentiation 28 (CD28) antagonist program for the treatment of autoimmune and inflammatory diseases; ALPN-202, a conditional CD28 costimulator and dual checkpoint inhibitor for the treatment of cancer; and ALPN-303, a dual B cell cytokine antagonist for the treatment of B cell-mediated inflammatory and autoimmune diseases. The company has a collaboration agreement with AbbVie Ireland Unlimited Company for the development of ALPN-101; and Adaptimmune Therapeutics plc to develop next-generation SPEAR T cell products. Alpine Immune Sciences, Inc. was incorporated in 2007 and is headquartered in Seattle, Washington.